SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Wanbury informs about press release

20 Dec 2024 Evaluate
Wanbury has informed that pursuant to Regulation 30 (6) of $EBI (Listing Obligations and Disclosure Requirements) Regulations, Wanbury's Tanuku plant at Andhra Pradesh successfully completed ANVISA inspection (Brazil Health Regulatory Agency) started from 16.12.2024 to 19.12.2024 (4 days) for its API manufacturing facility. Inspection completed with zero observations which means no observation during the inspection process for 5 APis confirming strict adherence of cGMP practices at its state-of-the art API manufacturing facility. The Company will receive GMP compliance certificate which will further help to accelerate the business growth across the globe since ANVISA (Agenica National De Vigilancia Sanitaria) is part of PIC (Pharmaceutical Inspection Convention). This is second international FDA inspection with zero observations this year after US FDA inspection completed in June 2024 at Patalganga plant also with zero observations. Wanbury is one of the largest manufacturer of Metformin HCI & Sertraline API in addition to other API's with few more are under final stage of development & set to be produced shortly in the said facility. This inspection validates management continued commitment to Quality of the APi's as per international regulations.

The above information is a part of company’s filings submitted to BSE.

Wanbury Share Price

259.05 -6.90 (-2.59%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×